Artal International Management S.A., Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 728,056 shares at $9.62 ($7.3M) on 2018-05-25, disclosed to the SEC on 2018-05-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.62 | 138,700 | $1.3M | 18.3% |
| 2 | $9.84 | 147,339 | $1.4M | 19.9% |
| 3 | $9.84 | 147,339 | $1.4M | 19.9% |
| 4 | $10.32 | 147,339 | $1.5M | 20.9% |
| 5 | $10.32 | 147,339 | $1.5M | 20.9% |
| Total | $9.99 avg | 728,056 |
| $7.3M |
| 100% |
| Filing → |
| LXRX | BUY | 2018-06-18 | $1.1M | — | Filing → |
| LXRX | BUY | 2018-06-07 | $8.2M | — | Filing → |
| WTW | BUY | 2014-08-14 | $2.9M | — | Filing → |